Celiac disease autoantibodies in severe autoimmune liver disease and the effect of liver transplantation
- 12 March 2008
- journal article
- Published by Wiley in Liver International
- Vol. 28 (4) , 467-476
Abstract
Background/aims: Celiac disease (CD) is associated with primary biliary cirrhosis, primary sclerosing cholangitis and autoimmune hepatitis. We investigated the following: (i) the prevalence of tissue transglutaminase antibodies (tTGAs) and endomysial antibodies (EMAs) in end‐stage autoimmune liver disease (ESALD), (ii) the correlation among auto‐antibodies and the human leucocyte antigen (HLA) haplotype, and (iii) the effect of liver transplantation on antibody kinetics.Methods: Pretransplantation sera from 488 patients (310 with ESALD, and 178 with non‐autoimmune disease) were tested for tTGAs. Positive samples were also tested for EMAs, and retested 6–12 and ≥24 months post‐transplantation. Results were correlated with the HLA type of the recipient.Results: Serological evidence of CD was found in 3% (ESALD) vs. 0.6% (non‐autoimmune) of the patients (five‐fold increased risk in ESALD). The prevalence of tTGAs (14.2 vs. 5.4%, P=0.0001) and EMAs (4.3 vs. 0.78%, P=0.01) was significantly higher in patients with the HLA‐DQ2 or HLA‐DQ8 haplotypes. tTGAs and EMAs normalized in 94 and 100%, respectively, without gluten exclusion post‐transplantation. Post‐transplantation, of the five patients with symptoms of ‘classical’ CD, three improved. Intestinal lymphoma was diagnosed in another two cases with clinically ‘silent’ CD.Conclusions: Patients with ESALD, especially those who are HLA‐DQ2 or HLA‐DQ8 positive had a high prevalence of CD‐associated antibodies. Both tTGAs and EMAs decreased post‐transplantation without gluten withdrawal. Immunosuppression may improve symptoms of CD, but might not prevent progression to intestinal lymphoma.Keywords
This publication has 45 references indexed in Scilit:
- Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experienceGut, 2007
- Hematologic manifestations of celiac diseaseBlood, 2006
- HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac diseaseJournal of Clinical Investigation, 2006
- False positive reactions for IgA and IgG anti-tissue transglutaminase antibodies in liver cirrhosis are common and method-dependentClinica Chimica Acta, 2005
- Systematic review: the liver in coeliac diseaseAlimentary Pharmacology & Therapeutics, 2005
- High prevalence of celiac disease in autoimmune hepatitis detected by anti-tissue tranglutaminase autoantibodiesJournal of Clinical Laboratory Analysis, 2005
- Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphomaGut, 2004
- High Rate of Positive Anti-Tissue Transglutaminase Antibodies in Chronic Liver DiseaseScandinavian Journal of Gastroenterology, 2003
- Hla-Dq Typing in The Diagnosis of Celiac DiseaseAmerican Journal of Gastroenterology, 2002
- HLA‐DQB1 and ‐DQA1 typing by PCR amplification with sequence‐specific primers (PCR‐SSP) in 2 hoursTissue Antigens, 1993